News & Updates

A retrospective, propensity score-matched analysis from Singapore demonstrates the feasibility of transanal total mesorectal excision with delayed coloanal anastomosis (TaTME-DCAA) as a surgical alternative for non-metastatic low rectal cancer.

During the launch of Nicorette^® QuickMist at the Kuala Lumpur Nicotine Addiction International Conference (KLNAC) 2023, a panel of distinguished experts led the discussion on the role of Nicotine Replacement Therapy (NRT) on smoking cessation management. The panel comprised of notable experts, including Professor Chris Bullen (New Zealand), Associate Professor Dr Amer Siddiq bin Amer Nordin (Malaysia), Dr Philip Tønnesen (Denmark) and Professor Philip Eng (Singapore).

The guanylate cyclase C agonist linaclotide helps increase the frequency of bowel movements in children with functional constipation, according to data from a phase III trial.

In advanced nonsmall cell lung cancer (NSCLC) patients with anorexia, treatment with mirtazapine leads to a substantial increase in energy intake despite having no effect on appetite, as shown in a study.

High-flow nasal cannula therapy (HFNT) is effective in reducing the intensity of the sensory and affective components of dyspnoea, independent of oxygen addition, suggests a study.

Oesophageal cancer survivors are more likely to develop late-onset pneumonia during their clinical course, a study suggests.

New drug applications approved by US FDA as of 01-15 January 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.